Similar documents
第61巻5・6号(12月号)/特集1頁目(本刷)

第64巻1・2号(4月号)/特集・Aはじめに P1

第59巻4,5号(10月号)/投稿規定・目次・表2・奥付・背


第62巻5・6号(12月号)/特集1・巻頭言




Unknown

β β β β β β

第57巻6号/投稿規定・目次・表2・奥付・背

untitled



第56巻2号/投稿規定・目次・表2・奥付け・背


第57巻4,5号/投稿規定・目次・表2・奥付・背

第57巻2号/投稿規定・目次・表2・奥付・背

表紙PDF作成用/PDF表紙作成用


肺癌第49巻第1号

研修コーナー

第86回日本感染症学会総会学術集会後抄録(I)

第58巻6号/投稿規定・目次・表2・奥付・背

第57巻3号/投稿規定・目次・表2・奥付・背

表紙63-5,6.eps

The Journal of the Japan Academy of Nursing Administration and Policies Vol 7, No 2, pp 19 _ 30, 2004 Survey on Counseling Services Performed by Nursi




表紙PDF作成用/PDF表紙作成用

明海大学歯学雑誌 37‐2/1.秦泉寺

Unknown

第56巻6号/投稿規定・目次・表2・奥付・背

2009年度 東京薬科大学 薬学部 授業計画

_0212_68<5A66><4EBA><79D1>_<6821><4E86><FF08><30C8><30F3><30DC><306A><3057><FF09>.pdf


表紙 eps

表紙PDF作成用/PDF表紙作成用

東洋医学雑誌

名大_医学部保健学科年報第8巻/巻頭

名称未設定-1

BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI

研修コーナー

パーキンソン病治療ガイドライン2002

CHEMOTHERAPY aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Prote

表紙PDF作成用/PDF表紙作成用

Yogo

A9R7022.tmp

26 1 : Self - reported Practices of Cancer Pain Management among Nurses in Tohoku University Hospital Hideyuki Hira

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study


(プロ1特別企画用ショート版) (詳細頁レ).indd

08医療情報学22_1_水流final.PDF

A9R7CAF.tmp


Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.

スライド 1

日本職業・災害医学会会誌第51巻第5号



日本消化器病学会雑誌第102巻第8号

第58巻3号/投稿規定・目次・表2・奥付・背

第63巻3・4号(8月号)/特集・巻頭言 P85

CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates

NL11

03_学術.indd

CHEMOTHERAPY

表紙PDF作成用/PDF表紙作成用


untitled

History I COE

CHEMOTHERAPY JUN Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter cloacae 27, Proteus rettgeri 7, Proteus inconstans 20, Proteus

Fig. 1 A: Effects of intramuscular injection of glucagon on the blood glucose levels (changes from basal, ƒ BG) as compared with effects of scopolamin

VOL.35 S-2 CHEMOTHERAPY Table 1 Sex and age distribution Table 2 Applications of treatment with carumonam Table 3 Concentration of carumonam in human




理学療法検査技術習得に向けた客観的臨床能力試験(OSCE)の試行

596 Dementia Japan 29 : , 2015 原著 1,2 1,2 1,3 1,4 1,4 1,5 1,5 1,6 1,7 1,8 要 旨 Activity of Initial - phase Intensive Support Team for Dementia o

大阪大学0623

_’£”R‡Ù‡©

semen quality or those without WBC in semen. In the patients with azoospermia and normal FSH levels (normogonadotropic azzospermia), the antibody (IgG

622 3) 4 6) ) 8) , ,921 40, ) ) 10 11) ) ) ,434 43, ,18

<95DB8C9288E397C389C88A E696E6462>

自大病院だより-23号-cs5.indd

東洋医学雑誌

!

VOL.32 S-7 CHEMOTHERAPY Table 1 MIC of standard strains of CTRX Fig. 2 Cumulative curves of MIC S. aureus (26 strains )

不安障害研究, 9(1), 17-32, 2017


特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

*特集〜資料01/ブック

indd

第90回日本感染症学会学術講演会抄録(I)

24回日本エイズ学会誌1_ indd

Professor of Epidemiology and Nutrition, Harvard School of Public Health Personal History 1945 Born in Hart, Michigan, USA 1970 M.D. University of Mic

2 10 The Bulletin of Meiji University of Integrative Medicine 1,2 II 1 Web PubMed elbow pain baseball elbow little leaguer s elbow acupun

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec LVFX 100 mg 3 / mg 2 / LVFX PK PD mg mg 1 1 AUC/MIC

udc-3.dvi

Transcription:

Special IssueDiagnoses and therapeutic agents for age-related diseases Reviews Original Case reports

β

Medicinal drugs affecting on clinical laboratory blood test results and adverse effects of them Masaki Imanishi Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan

Pathological Examinations and Cancer Drugs Michiko Yamashita Tokushima Red Cross Hospital, Division of Diagnostic Pathology, Tokushima, Japan

α

The role of iron, a trace nutrient, on diabetes Yasumasa Ikeda Department of Pharmacology, Institute of Biomeclical Sciences, Tokushima University Graduate School, Tokushima, Japan

μ μ et al et al

et al et al íé et al et al et al et al et al et al et al et al et al et al et al et al et al et al

et al et al et al

Osteoporosis : from pathophysiology to therapeutic approach Itsuro Endo Department of Chronomedicine, Tokushima University Graduate School of Medical Sciences, Tokushima, Japan

,

β

et al et al et al et al et al et al et al et al et al κ et al et al et al et al

et al et al

Molecular pathological diagnosis for personalized medicine Hisanori Uehara Division of Pathology, Tokushima University Hospital, Tokushima, Japan

μ

α

Basic and Clinical Science, and Clinical Practice for Prevention of Lifestyle-related Diseases Ken-ichi Aihara Department of Community Medicine for Diabetes and Metabolic Disorders, Tokushima University Graduate School of Biomedical Sciences, Kuramoto-cho Tokushima, Japan

α βαβ

egfr

β

β et al et al et al et al

et al et al et al A study on 80 patients with type 2 diabetes who were administered SGLT2 inhibitor at our clinic. SGLT2 inhibitor is the strongest drug for treating diabetic nephropathy Takashi Inomoto Inomoto Clinic Ophthalmology and Internal medicine, Internal medicine, Tokushima, Japan

et al et al et al et al

Selective lobar blockade for lung resection : A report of two cases Naoya Kawakita, Hiroaki Toba, Shoji Sakiyama, Toru Sawada, Mitsuhiro Tsuboi, Mitsuteru Yoshida, Yukikiyo Kawakami, Hiromitsu Takizawa, Kazuya Kondo, and Akira Tangoku Department of Thoracic and Endocrine Surgery and Oncology, Institute of Health Biosciences, the University of Tokushima Graduate School, Tokushima, Japan Department of Thoracic Surgery, Kochi National Hospital, Kochi, Japan Department of Oncological Medical Services, Graduate School of Biomedical Biosciences, the University of Tokushima Graduate School, Tokushima, Japan

μ

et al et al et al et al

et al

A case of Jujunal diverticulitis with enterolith in elderly patient Which was successfully treated by laparoscopic assisted operation Yoshifumi Tagami, Katuhiro Masamune, and Sadahiro Yoshida Department of Surgery, Anan Kyoei Hospital, Tokushima, Japan

α

αα α α α α

T-BOX 15GRHL 2Gab 1 T-Box 15 β β T-Box 15 p<0.0001 T-Box 15 T-Box 15 T-Box 15 T-Box 15 Campylobacter jejuni Campylobacter jejuni C. jejuni C. jejuni C. jejuni C. jejuni

αβ α αβ α αβ β

β

CDKN 1 A BBC 3 CDKN 1 A BBC 3 BAX TP 53 INP 1 BCL 6BIRC 3

α μ μ μ

μ κ λ

Editor-in-Chief Editors Published by Tokushima Medical Association in